
BEVERLY, Mass.–(Small business WIRE)–Quantabio, a top service provider of robust DNA and RNA amplification reagents for the most demanding molecular tests and everyday living science analysis programs, right now announced the business availability of the qScript Ultra Flex Package and the qScript Extremely SuperMix for the synthesis of very first-strand complementary DNA (cDNA). Both items are section of the new qScript Extremely product relatives, which features the company’s new reverse transcriptase (RT) enzyme technological innovation that appreciably improves item general performance, speed and relieve of use. Scientists are now equipped to conquer prevalent PCR inhibitors and reverse transcribe prolonged RNA targets from a broad array of complicated enter portions in an impartial fashion in only 10 minutes.
cDNA synthesis from RNA is an vital first stage in lots of gene expression evaluation and pathogen detection purposes that benefit from true-time quantitative PCR (qPCR) or future-era sequencing (NGS).
These assignments require sturdy enzyme systems and priming selections to deliver cDNA products or libraries that precisely depict the initial RNA transcripts. The extremely efficient and exact qScript Ultra products optimize cDNA yields for downstream examination. Compared to alternative systems, the new Quantabio solutions supply many exceptional pros, together with:
- Improved Thermostability: Engineered for best RT exercise from 55 to 60° C (65° C greatest)
- Outstanding Speed: 10-minute response time with a full protocol time of 13 minutes
- Optimum Produce & Sensitivity: Wide linear dynamic vary with regular and productive cDNA conversion from 2.5 μg – 1 pg of complete RNA
- Best Inhibitor Resistance: Triumph over a extensive array of PCR inhibitors (salt, heparin, melanin, and many others.)
- Balanced Protection of Lengthy Transcripts: Capability to reverse transcribe solitary targets up to 20 kb and develop an unbiased illustration of the transcriptome
“Since our founding in 2001, Quantabio has produced a in depth portfolio of field-primary RNA and DNA enzyme and reagent systems for everything from life science and translational investigate to serious-world SARS-CoV-2 screening to new child screening,” mentioned David Schuster, Head of R&D at Quantabio. “The new qScript Extremely merchandise family was formulated based on direct suggestions from our buyers. To enable fulfill the escalating need for these upcoming-generation items, we are now growing headcount and scaling our professional organization to unlock more markets.”
The qScript Ultra SuperMix is a highly steady, effective and straightforward-to-use single tube learn blend for very first-strand synthesis that delivers quick and reproducible outcomes with an impartial illustration of RNA sequences in cDNA. It is directly appropriate with downstream 2-step RT-qPCR or RT-PCR processes and is preferably suited for gene expression or RNA pathogen quantification research. The kit is available in 25, 100 or 500 reactions and is made up of all needed components for first-strand cDNA synthesis other than RNA template. For more information, please visit https://www.quantabio.com/solution/qscript-ultra-supermix/.
The qScript Extremely Flex Package provides flexible, person-described priming solutions, which include oligo-dT, random primers and/or gene-precise priming to reverse transcribe RNA to cDNA. The kit includes all demanded elements for 1st-strand cDNA synthesis besides RNA template and gene-unique primers. Out there in 25 or 100 reactions, the package is appropriate with downstream 2-action RT-qPCR or RT-PCR procedures. For extra info, please check out https://www.quantabio.com/item/qscript-ultra-flex-kit/.
About Quantabio
Quantabio is a major supplier of advanced DNA and RNA amplification reagents for the most demanding molecular tests programs in utilized, translational and life science investigate. For the earlier 20 decades, the Quantabio crew has been building revolutionary amplification technologies to produce cutting-edge merchandise to scientists concentrated on crucial PCR, qPCR and Future-Technology Sequencing (NGS) centered purposes. Dependent in Beverly, Mass., Quantabio delivers a growing portfolio of products and solutions via its international profits functions, as effectively as a worldwide network of distributors and commercial support suppliers. For much more information, remember to check out www.quantabio.com.
Quantabio products are intended for molecular biology applications. This products is not intended for the diagnosis, avoidance, or procedure of a disease.